Frequently Asked Questions

Common Questions & Answers

If you have any questions about receiving the vaccine please contact your medical care provider.

Here are answers to some commonly asked questions. For further information visit the CDC website.

  • Am I eligible to receive the vaccine?
    All community members ages 18+ are now eligible to receive the COVID-19 vaccine at no cost.
  • Do I have to be a resident of mesquite to receive the vaccine?
    At this time we are offering vaccinations to full time and seasonal residents of Mesquite, Bunkerville, the Moapa Valley, and Arizona Corridor of Scenic, Beaver Dam, and Littlefield.
  • What do I do if I'm unable to print the needed form?
    Forms are available for pick up at the following locations:
    - Hospital Information Desk
    - City Hall
  • Are the forms available in Spanish?
    Yes. You can download the forms in Spanish here or pick them up at these local locations:
    Hospital Information Desk
    City Hall
  • What if I have to cancel my appointment?
    If it is necessary to cancel your appointment, please call SNHD at 702-759-1682, reply to your confirmation email or email appointments@vaccinatemesquitenv.org
  • How do I make my appointment for the second dose?
    If you need to make an appointment for a 2nd dose, please contact a local pharmacy. SNHD is unable to schedule a 2nd dose if you received your 1st dose somewhere other than Rising Star.
  • How is the vaccine administered?
    The vaccine is administered as an injection in the upper arm in two doses, 28 days apart.
  • How effective is the vaccine?
    Both vaccines have shown incredibly promising results in clinical trials. preliminary data from the phase 3 trial of the Pfizer/Biontech vaccine demonstrated that the vaccine is 95 percent effective in preventing COVID-19. This efficacy was consistent across different age groups, gender, race and ethnicity demographics. The observed efficacy in adults over the age of 65 was greater than 94 percent.
  • COVID-19 vaccine how safe is the vaccine?
    The Moderna vaccine has demonstrated exceptional safety profiles in clinical studies.
  • When should I expect to have sufficient immunity following vaccination?
    One week after the second dose, vaccine recipients should have significant immunity to COVID-19.
  • Can people who are immunocompromised receive the vaccine?
    At this point, there is insufficient evidence to recommend for or against the vaccine among immunocompromised people. Please see your health care provider if you have any questions or concerns.
  • Can I get covid-19 from the vaccine?
    No, it is not possible to contract COVID-19 from the vaccine. This advanced vaccine does not contain the virus.
  • What if I contract COVID-19 between the first and second doses?
    If you are diagnosed with covid-19 between doses of the vaccine, please complete your period of isolation and wait until all covid-19 symptoms have completely resolved before receiving your second dose.
  • If I had COVID-19 in the past, should I be vaccinated?
    Although infection with COVID-19 does provide some degree of natural immunity, this may not last very long. Those who have previously recovered from covid-19 should receive the vaccine. For those who have received passive antibody treatment forCOVID-19, including convalescent plasma and monoclonal antibodies, such as Regeneron, the CDC recommends waiting at least 90 days after the treatment to receive the vaccine, as a precautionary measure until additional information becomes available, to avoid interference of the antibody treatment with vaccine-induced immune responses.
  • After receiving the vaccine, should I continue to follow other mitigation measures such as wearing a mask and maintaining social distancing?
    Yes, please continue to follow all of the established guidelines to prevent the spread of COVID-19. as we continue to learn more about the level of protection covid-19 vaccines provide in real-life conditions, we must continue to use all the tools at our disposal to help stop this pandemic. This includes covering your mouth and nose with a mask, performing frequent hand hygiene and staying at least 6 feet away from others.
  • Can women who are pregnant or those who are lactating receive the vaccine?
    Women who were pregnant or lactating were excluded from the clinical trials for both COVID-19 vaccines. At this time, there is insufficient data to recommend for or against vaccination in this group.
  • What happens if I skip the second dose of the vaccine?
    Those who skip the second dose may not develop a sufficient level of antibodies.
  • I have a history of severe allergies that are not related to vaccines or injectable therapies. can I receive the vaccine?
    Yes, the Moderna vaccine is available to people who have a history of allergic reactions that are not related to vaccines or injectable therapies (e.g., food, pet, venom, environmental, latex, oral medications), including severe allergic reactions. The CDC has not identified these types of allergic reactions as contraindications or precautions for either of the available vaccines. However, individuals who have had severe allergic reactions to something, regardless of cause, will be observed for 30 minutes after vaccination, rather than the standard 15-minute observation period.
  • Can I get vaccinated if I’ve had a severe allergic reaction to the covid-19 vaccine or another vaccine?
    You should not receive the vaccine if you have experienced a severe allergic reaction (e.g. anaphylaxis) to a previous dose of the Pfizer/Biontech or Moderna COVID-19 vaccines or to a component of the vaccines. additional precautions are required for people who have had severe allergic reactions (e.g. anaphylaxis) to a previous dose of any other vaccine or injectable medication. While these individuals may receive the COVID-19 vaccine, they should be aware of the unknown risks of developing a severe allergic reaction and balance these risks against the benefits of vaccination. These individuals will be observed for 30 minutes after vaccination.